AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
slide-0
slide-1

Glimigard-M2 Tablet SR

Prescription Icon
Prescription Required

Marketer

Astraea Life Sciences Pvt Ltd

Salt Composition

Glimepiride (2mg) + Metformin (500mg)

Overview Glimigard-M2 Tablet SR

DiabetaComb SR tablets are a dual-action antidiabetic medication, effective in managing type 2 diabetes in adults. This combination therapy helps regulate blood glucose levels. DiabetaComb SR should be ingested with food, consistently at the same time daily for optimal results. Dosage is determined and adjusted by your physician based on your blood sugar readings. Continued use is crucial, even with controlled glucose levels or feeling well; abrupt cessation without medical supervision can elevate blood sugar, potentially leading to complications including kidney impairment, vision loss, neuropathy, and limb amputation. This medication complements a comprehensive diabetes management plan encompassing a balanced diet, regular exercise, and weight management as directed by your doctor. Lifestyle choices significantly impact diabetes control. Hypoglycemia (low blood sugar) is a common side effect, characterized by symptoms like sweating, dizziness, headache, and tremors. Regular meals and readily available glucose sources (e.g., sugary snacks or juice) are essential for prevention. Alcohol consumption should be minimized due to its potential to exacerbate hypoglycemia. Additional potential side effects include altered taste perception, nausea, diarrhea, abdominal discomfort, headache, and upper respiratory infections. Weight gain is possible. This medication is contraindicated in patients with type 1 diabetes, diabetic ketoacidosis, or severe hepatic or renal impairment. Individuals with a history of cardiac disease should inform their physician prior to initiating treatment. Pregnant or lactating women should seek medical advice before use. Regular blood glucose monitoring and periodic blood tests (to assess blood cell counts and liver function) are recommended by your doctor.

Uses of Glimigard-M2 Tablet SR

Managing type 2 diabetes

Major Benefits of Glimigard-M2 Tablet SR:

Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Glimigard-M2 Tablet SR should be administered with a meal.

Common Side effects of Glimigard-M2 Tablet SR:

  • Headache
  • Hypoglycemia (low blood glucose level)
  • Nausea
  • Diarrhea

How to use Glimigard-M2 Tablet SR:

Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. It's recommended to take Glimigard-M2 Tablet SR with a meal.

How Glimigard-M2 Tablet SR works:

Glimigard-M2 SR tablets contain a dual-action antidiabetic formulation: glimepiride and metformin. Glimepiride, a sulfonylurea, stimulates pancreatic insulin secretion, thus reducing blood sugar levels. Metformin, a biguanide, acts through a three-pronged mechanism: reducing hepatic glucose output, inhibiting intestinal glucose absorption, and enhancing insulin sensitivity.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining Glimigard-M2 Tablet SR and alcohol is unsafe.

PregnancyPregnancyCONSULT YOUR DOCTOR

Using Glimigard-M2 Tablet SR during pregnancy may pose risks. While human research is scarce, animal studies indicate potential harm to a developing fetus. A physician will assess the advantages against possible dangers prior to prescribing. Consult your doctor for guidance.

Breast feedingBreast feedingUNSAFE

Sustained-release Glimigard-M2 tablets are contraindicated for breastfeeding mothers. Evidence indicates potential infant toxicity from this medication.

DrivingDrivingCAUTION

Driving may be impaired by excessively low or high blood sugar levels. Refrain from driving if such symptoms arise.

KidneyKidneyCAUTION

Exercise caution when administering Glimigard-M2 Tablet SR to individuals with impaired renal function; dosage modification may be necessary. Consult a physician for guidance. Glimigard-M2 Tablet SR is contraindicated in patients exhibiting severe kidney disease. Routine monitoring of kidney function is recommended during treatment.

LiverLiverCAUTION

Patients with liver impairment should use Glimigard-M2 Tablet SR cautiously, potentially requiring dosage modification. Consult a physician. A reduced initial dose is typically prescribed for individuals with mild to moderate hepatic dysfunction; however, its use is contraindicated in those with severe liver disease.

What if you forget to take Glimigard-M2 Tablet SR :

Should you forget a Glimigard-M2 Tablet SR dose, administer it immediately. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Glimigard-M2 Tablet SR

LabelValue
Potential for Dependence None.
Medication Classification Medication for diabetes

FAQs on Glimigard-M2 Tablet SR

Maintain this medication within its original, tightly sealed container. Follow the storage guidelines provided on the packaging. Discard any leftover medication. Ensure it remains inaccessible to children, pets, and others.
Glimigard-M2 Tablet SR use can result in lactic acidosis, a serious medical condition characterized by excessive blood lactic acid. Also termed Metformin-associated lactic acidosis (MALA), this is an infrequent but potentially harmful side effect, particularly for individuals with kidney impairment, the elderly, or those who consume significant alcohol. Symptoms may manifest as muscle aches or weakness, lightheadedness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal discomfort, or a slow pulse. Should these symptoms appear, discontinue Glimigard-M2 Tablet SR and seek immediate medical attention.
The extended-release Glimigard-M2 tablet combines glimepiride and metformin to manage type 2 diabetes mellitus in adults. This dual-action medication enhances glycemic control when coupled with a healthy diet and regular physical activity. Glimepiride functions by stimulating pancreatic insulin secretion, while metformin reduces hepatic glucose production and improves insulin responsiveness. This formulation is unsuitable for treating type 1 diabetes.
Glimigard-M2 Tablet SR may cause common side effects including low blood sugar (hypoglycemia), taste changes, nausea, abdominal pain, diarrhea, and headaches. Rare but potentially serious adverse reactions such as lactic acidosis may occur. Prolonged treatment may result in vitamin B12 deficiency.
Prolonged Glimigard-M2 Tablet SR administration can indeed lead to Vitamin B12 deficiency. This medication impairs the body's absorption of Vitamin B12. Left unaddressed, this deficiency may result in anemia, neurological complications such as tingling and numbness in the extremities, muscle weakness, urinary dysfunction, cognitive changes, and impaired coordination. Preventive measures, according to some studies, include supplemental Vitamin B12 at least annually.
Indeed, Glimigard-M2 Tablet SR can induce hypoglycemia, characterized by low blood glucose. Manifestations of low blood sugar may encompass nausea, headache, irritability, hunger pangs, sweating, vertigo, tachycardia, and feelings of anxiety or tremor. This adverse effect is amplified by skipped or delayed meals, alcohol consumption, excessive physical activity, or concomitant use of other antidiabetic medications. Consequently, consistent blood glucose monitoring is crucial. Carrying a readily available fast-acting sugar source, such as glucose tablets, honey, or fruit juice, is advisable.
Consuming alcohol while taking Glimigard-M2 Tablet SR is unsafe. This combination may cause dangerously low blood sugar (hypoglycemia) and heighten the risk of lactic acidosis.
Glimigard-M2 Tablet SR
45
MRP 55
18% off